Table 4 Treatment outcomes
Characteristic | Glutamine (+) | Glutamine (−) | P-value |
|---|---|---|---|
| Â | (N=56) | (N=48) | Â |
Maximum grade ARIE (N; %) | Â | Â | Â |
0–1 | 40 (71.4) | 21 (43.7) | 0.02 |
2 | 37.0 | 34.2 | Â |
3 | 27.8 | 22.8 | Â |
4 - 5 | 0 (0) | 0 (0) | Â |
Grade 2–3 ARIE onset (days) |  |  |  |
Median | 24.5 | 16.4 | 0.001 |
Range | (17 – 32) | (9–23) |  |
Treatment delay (N; %) | 4 (7.1) | 10 (20.8%) | 0.04 |
Hospitalization | 2 (3.6) | 3 (6.3) | 0.14 |
Weight change (N; %) | Â | Â | Â |
No change or gain | 31 (55.4) | 13 (27.1) | 0.002 |
Loss | 25 (44.6) | 35 (72.9) | Â |
Weight change (kg) | Â | Â | Â |
Median | 2.6 | −3.3 | < 0.001 |
Range | (−3.1 to 7.6) | (−9.7 to 2.3) |  |
Weight change (%) | Â | Â | Â |
Median | 3.94 | −4.91 | < 0.001 |
Range | (−4.7 to 11.5) | (−14.4 to 3.4) |  |
LET (maximum grade) | Â | Â | Â |
2 | 2 (3.6) | 3 (6.3) | 0.06 |
3 | 0 (0) | 3 (6.3) | Â |
4 - 5 | 0 (0) | 0 (0) | Â |